Larvol Delta - Retina-Society-2023-Phase-3-studies-of-dual-inhibition-of-VEGF-CD-and-VEGF-A-using-OPT302-in-combination-with-ranibizumab-or-aflibercept-in-neovascular-AMD

OPT-302 - Opthea

https://www.modernretina.com/view/retina-society-2023-phase-3-studies-of-dual-inhibition-of-vegf-c-d-and-vegf-a-using-opt-302-in-combination-with-ranibizumab-or-aflibercept-in-neovascular-amd

Oct 16, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next